Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human RKIP ELISA Kit (AC3651)
Cat.#: ASET-2240
Specifications
Description Human RKIP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human RKIP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.029 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1323 Rat Glutamine Synthetase ELISA Kit (AC2734) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-2216 Human Insulin Receptor ELISA Kit (AC3627) Quantitative inquiry ASET-1118 Mouse Ephrin A4 ELISA Kit (AC2529) Quantitative inquiry ASET-1046 Human TIMP3 ELISA Kit (AC2457) Quantitative inquiry ASET-1703 Rat NMDAR2A ELISA Kit (AC3114) Quantitative inquiry ASET-1261 Rat AKR7A2 ELISA Kit (AC2672) Quantitative inquiry ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry ASET-1678 Mouse Twist ELISA Kit (AC3089) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket